39 results
10-Q
2024 Q1
ADCT
Adc Therapeutics SA
6 May 24
Quarterly report
6:38am
to valuation follows the fair value principle, and the key input factors are described for the Deerfield warrants in note 10, "Deerfield warrants." A Black … the Black-Scholes option-pricing model. Key inputs for the valuation of the warrant obligation as of March 31, 2024 and December 31, 2023 were
8-K
EX-99.2
ADCT
Adc Therapeutics SA
6 May 24
ADC Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
6:29am
White non-Hispanic White Hispanic Black MZL type 11 (73%) 3 (20%) 1 (7%) EMZL, n (%) NMZL, n (%) SMZL, n (%) 15ECOG 0 – 1 Stage 2 0 3 10 I II III IV 2
10-K
2023 FY
ADCT
Adc Therapeutics SA
13 Mar 24
Annual report
12:25pm
on the date of grant using the Black-Scholes option valuation model, that requires the use of assumptions including the expected volatility … warrants." A Black-Scholes model was used to calculate the fair values.
There were no transfers between the respective levels during the period.
4
6-K
EX-99.1
ADCT
Adc Therapeutics SA
7 Nov 23
Condensed Consolidated Interim Statement of Operations
7:13am
, "Senior secured term loan facility and warrants" and for the Deerfield warrants in note 15, "Deerfield warrants." Commonly accepted pricing models (Black … information.
The Company used an independent valuation firm to assist in calculating the fair value of the warrant obligations, using the Black-Scholes option
6-K
EX-99.1
ADCT
Adc Therapeutics SA
8 Aug 23
Condensed Consolidated Interim Statement of Operations
7:07am
, "Senior secured term loan facility and warrants" and for the Deerfield warrants in note 15, "Deerfield warrants." Commonly accepted pricing models (Black … )" for further information.
The Company used an independent valuation firm to assist in calculating the fair value of the warrant obligations, using the Black
6-K
EX-99.1
u4nxlw09rykm u25l
9 May 23
Condensed Consolidated Interim Statement of Operations
6:06am
6-K
EX-99.3
xonc1lb20r 1xnxxg
5 May 23
Invitation to the Annual General Meeting
8:00am
6-K
EX-99.4
kq2u9y
5 May 23
Invitation to the Annual General Meeting
8:00am
6-K
EX-99.1
4c84wbaxvslsa
8 Nov 22
Condensed Consolidated Interim Statement of Operations
7:06am
6-K
EX-99.1
xwwramyhnkm3
15 Aug 22
Current report (foreign)
5:17pm
6-K
7baiw3dowrw
15 Aug 22
Current report (foreign)
5:17pm
6-K
EX-99.1
yj6b9t9jq5qmv
9 Aug 22
Condensed Consolidated Interim Statement of Operations
7:23am
6-K
EX-99.1
b8rpvdu7dn zch7u7pba
9 May 22
Condensed Consolidated Interim Statement of Operations
7:15am
6-K
EX-99.3
l9mdy3w8
17 Mar 22
Current report (foreign)
4:06pm
6-K
EX-99.2
u0rgjdu
17 Mar 22
Current report (foreign)
4:06pm
6-K
EX-99.4
f4ofabmp ra
17 Mar 22
Current report (foreign)
4:06pm
6-K
EX-99.1
507rz 3g78ygqg
2 Nov 21
Condensed Consolidated Interim Statement of Operations
7:08am
6-K
EX-99.1
bf9tceh06 oibz
3 Aug 21
Condensed Consolidated Interim Statement of Operations
7:07am
6-K
EX-99.1
ui0i1bm
6 May 21
Condensed Consolidated Interim Statement of Operations
7:08am